Nizatidine (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Nizatidine drug offered from Mylan Pharmaceuticals Inc.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | nizatidine |
| SUBSTANCE NAME: | NIZATIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2002-07-10 |
| END MARKETING DATE: | 0000-00-00 |
Nizatidine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nizatidine from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2002-07-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-5150_33f217b5-71b8-4773-936b-c6046b78e2a7 |
| PRODUCT NDC: | 0378-5150 |
| APPLICATION NUMBER: | ANDA075806 |
Other NIZATIDINE Pharmaceutical Manufacturers / Labelers:
